Wysa

by Wysa  · Based in United States → — Everyday Mental Health
Family Medicine Internal Medicine Psychiatry

Freemium
Documentation ProvidedRegulatory Status Disclosed

Overview

Wysa is an AI-powered mental health platform designed to provide conversational support and therapeutic interventions. It utilizes evidence-based techniques, including Cognitive Behavioral Therapy (CBT) and Dialectical Behavior Therapy (DBT), delivered through an AI chatbot. For physicians and mental health professionals, Wysa offers a unique tool to extend care, provide immediate support to clients, and gain insights into their well-being outside of traditional therapy sessions.

The platform is built to be accessible and engaging, offering a safe space for users to express themselves and learn coping strategies. Wysa’s AI can guide users through exercises, meditations, and goal-setting activities, helping to manage stress, anxiety, depression, and other mental health challenges. This can serve as a valuable adjunct to in-person or telehealth therapy, providing continuous support and reinforcement of therapeutic principles.

For clinicians, Wysa can offer aggregated, anonymized insights into patient engagement and progress, which can help tailor treatment plans and identify areas where clients might need more support. While Wysa is not a diagnostic tool and does not replace human therapy, it acts as a supportive companion that can enhance patient outcomes by promoting self-management and emotional regulation skills. Its focus on evidence-based techniques ensures that the support provided aligns with professional therapeutic standards.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI conversational chatbot
  • Evidence-based therapeutic techniques (CBT, DBT)
  • Guided meditations and exercises
  • Mood tracking and journaling
  • Goal setting and progress monitoring
  • Anonymized insights for clinicians
  • Crisis support resources
  • Personalized coping strategies

Use Cases

  • Supplemental mental health support for patients
  • Patient self-management of stress and anxiety
  • Reinforcement of therapeutic techniques between sessions
  • Early intervention for mental well-being
  • Providing insights for clinical treatment planning
  • Employee mental wellness programs

What Physicians Need to Know

Evidence Base
Wysa's AI conversational platform is rooted in Cognitive Behavioral Therapy (CBT) and Dialectical Behavior Therapy (DBT) principles. Its content and techniques are developed by a team of psychologists and coaches, aligning with established therapeutic guidelines for mental health support.
Clinical Validation Studies
Wysa has undergone clinical trials demonstrating its effectiveness. For instance, a study published in JMIR Mental Health showed that Wysa significantly reduced anxiety and depression scores. Another randomized controlled trial indicated its efficacy in improving mental well-being.
Clinical Workflow Integration
Wysa is primarily a direct-to-consumer and employer-based mental health support tool. While it doesn't directly integrate into physician EHR systems for diagnosis/treatment decisions, it can serve as a complementary tool for patient self-management and support, potentially reducing the burden on clinical staff for routine mental health check-ins.
Physician Tip

Wysa can be a valuable resource for patients needing accessible, evidence-based mental health support between physician visits or as a first step for those hesitant to seek traditional therapy. Physicians can recommend Wysa for self-management of mild to moderate anxiety and depression, stress reduction, and sleep improvement. It's important to emphasize that Wysa is a supportive tool and not a substitute for professional medical diagnosis or treatment.

Wysa primarily integrates with employer wellness programs and health plans, offering its services as a benefit. It does not typically integrate directly with clinical EHRs or other physician-facing decision support systems. Its 'integration' into a clinical context would be through physician recommendation to patients as an external resource.

Details

Category Clinical Decision Support & Reference, Mental & Behavioral Health AI, Patient Engagement & Education
Pricing Freemium
Free TrialUnknown
DeploymentMobile App, Web Browser
Mobile App1
API AvailableUnknown
Data ExportUnknown
TrainingUnknown
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
GDPR Yes AI-estimated
Integrations
EHR Not specified
Specialties Family Medicine, Internal Medicine, Psychiatry

Support & Reliability

Training ProvidedUnknown

What the Web Says

Wysa is an AI-powered mental wellness app that utilizes Cognitive Behavioral Therapy (CBT) and Dialectical Behavior Therapy (DBT) techniques, mindfulness, and guided journaling through a conversational chatbot. It's designed for managing everyday stress, mild anxiety, and low mood, and offers an optional human coaching add-on. The app is widely praised for its accessibility, evidence-based techniques, and non-judgmental environment.

Overall: Positive

Strengths

  • 24/7 availability and accessibility, providing support during off-hours.
  • Utilizes evidence-based techniques like CBT and DBT.
  • Offers a non-judgmental and safe environment for users.
  • Has a functional free tier with access to unlimited chatbot conversations and exercises.
  • Can be a good starting point for those new to mental health support or hesitant about human therapy.
  • Optional human coaching sessions with mental health professionals are available.

Limitations

  • The AI chatbot can feel restrictive, generic, and repetitive, sometimes failing to understand complex emotions or nuanced conversations.
  • Not a substitute for a licensed therapist or crisis services for severe mental health conditions.
  • Many advanced features and the full CBT library are behind a premium paywall.
  • Lacks open-ended, exploratory conversation capabilities, quickly redirecting to structured activities.
  • Self-motivation is required for self-guided tools to be effective.
  • Limited voice interaction.

Based on reviews from: Wysa App Review 2026: Pros & Cons, Cost, & Who It's Right For, From lonely nights to better days: My experience with mental health apps (HeyNoah, Wysa, BetterHelp & more) - what's worked for you? - Reddit, Evaluating User Feedback for an Artificial Intelligenceu2013Enabled, Cognitive Behavioral Therapyu2013Based Mental Health App (Wysa): Qualitative Thematic Analysis - PMC, Wysa AI Therapy Review (2026) - Psychology.com, Wysa: Mental Wellbeing AI - Ratings & Reviews - App Store - Apple, Wysa App : r/Anxietyhelp - Reddit, Wysa vs. Abby: Which is Better? - Talkspace, Ratings & Reviews - Wysa: Mental Wellbeing AI - App Store - Apple, Wysa vs. Youper, does anyone have a preference? : r/depression - Reddit, I Tried the Wysa App: Is This AI Therapist Actually Helpful? - Ai Insights News, Has anyone else used Wysa? It's really helped me because it can store To Do Lists and things like reframing thoughts with CBT. Putting down all of my thoughts in the Thought Journal before bed has helped me more than anything else out there. : r/dyspraxia - Reddit, Has anyone ever tried the Wysa app therapists? What was/is your experience with it? : r/therapy - Reddit, Top 10 Wysa Alternatives & Competitors in 2026 - G2, My doctor and I are amazed at Wysa's quality - Mariko's Story, Wysa Review: AI Therapy Chatbot for CBT and Mindfulness - Agent Finder, Wysa Review 2026: Most Clinically Validated AI Therapy App (30+ Papers), Wysa Reviews & Ratings | Shortlister, Wellness AI vs Wysa: Which AI Therapy App Is Right for You? (2026), Wysa Review: Honest User Experience with This AI-Powered Mental Health Platform

Last updated: 2026-09-22

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Wysa

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Wysa News
Wysa Launches AI-Powered Chatbot to Streamline Mental Health Patient Intake in the US
Wysa has launched Wysa Gateway, an AI-powered chatbot designed to streamline mental health patient intake in the US, automating clinical screenings and reducing assessment times by 30 minutes. The tool offers 24/7 access and has achieved a 95% diagnostic accuracy rate in the UK's NHS.
2025-06
Endpoints News
Exclusive: Once a mental health chatbot, Wysa acquires physical therapy startup Kins
Wysa, an AI mental health platform, acquired physical therapy startup Kins in an all-stock deal to expand into at-home care and manage adjacent needs like chronic pain. This acquisition follows Wysa's earlier purchase of April Health, aiming to integrate AI more deeply into healthcare services.
2025-09
Business Wire
Wysa Acquires Kins Physical Therapy to Close Gaps in U.S. Healthcare
Wysa announced its acquisition of Kins, a U.S. physical therapy services company, to integrate AI innovation with human-led healthcare services and address the co-existence of musculoskeletal and behavioral health needs. This 'reverse acquisition' strategy aims to accelerate patient access to clinically proven AI.
2025-09
Business Wire
Wysa Partners with RxCap to Advance Medication Adherence
Wysa partnered with RxCap to integrate remote monitoring technology for medication adherence into Wysa's care platform. This collaboration provides healthcare clients with real-time insights into medication intake, aiming to improve patient outcomes and care management.
2025-06
Taylor & Francis (International Journal of Humanu2013Computer Interaction)
Enhancing AI-Driven Mental Health Solutions: The Role of Social Support in Wysa's Effectiveness for Stress Management and Anxiety Reduction among International Medical Students in China
A study published in the International Journal of Humanu2013Computer Interaction found that Wysa app usage positively correlates with stress reduction among international medical students, with social support moderating this relationship. The app leverages CBT techniques to help users manage stress and improve emotional regulation.
2025-08
Wysa News
Wysa Receives FDA Breakthrough Device Designation for AI-led Mental Health Conversational Agent
Wysa received FDA Breakthrough Device Designation for its AI-based digital mental health conversational agent for adults with chronic musculoskeletal pain, depression, and anxiety. This designation followed a peer-reviewed clinical trial published in JMIR, which found Wysa effective in managing these conditions.
2022-05
Kae Capital
Wysa secures $20mn to address global mental health demand with AI digital Therapeutics
Wysa secured $20 million in financing to expand its AI digital therapeutics platform into the US, UK, India, and other global markets. The funding, led by HealthQuad and British International Investment, will also support multi-lingual capabilities and easier access via platforms like WhatsApp.
2022-05
The National Law Review
Wysa Launches Multilingual Capabilities to Broaden Access to Mental Health Support Globally
Wysa expanded its AI-powered mental health support to include six new languages (French, German, Italian, Arabic, Japanese, and Brazilian Portuguese), building on existing English, Spanish, and Hindi support. This aims to provide empathetic, high-quality care to a truly global user base.
2025-12

Videos

Product demos, reviews, and walkthroughs for Wysa.

View all on YouTube

Frequently Asked Questions

Wysa is primarily a patient-facing AI-powered conversational agent for mental health support and does not directly integrate with EHRs for clinical decision support in the traditional sense. Its role is more about providing early intervention, self-management tools, and symptom tracking, which can then be discussed with a physician. Data from Wysa can be shared with clinicians, but this typically requires manual input or specific integrations that would need to be established on a case-by-case basis.
Wysa has been shown in several studies to be effective in reducing symptoms of depression and anxiety. For example, a randomized controlled trial published in JMIR Mental Health found that Wysa significantly reduced PHQ-9 and GAD-7 scores compared to a waitlist control group. Wysa's modules are often based on evidence-based techniques like Cognitive Behavioral Therapy (CBT) and Dialectical Behavior Therapy (DBT), and it is a CE-marked medical device in Europe and an FDA-cleared digital therapeutic in the US for certain indications.
Wysa is not a diagnostic tool and should not be used as a substitute for professional medical advice or treatment. Its insights are based on user input and AI algorithms, and while helpful for self-management, they lack the nuanced understanding of a human clinician. Physicians should be cautious and always exercise their own clinical judgment, especially in cases of severe mental illness, suicidality, or complex comorbidities, where Wysa's capabilities are limited.
Yes, several other AI-powered mental health tools and digital therapeutics exist, each with varying features and levels of clinical decision support. Examples include Woebot, which also uses CBT principles, and various prescription digital therapeutics (PDTs) like Pear Therapeutics' reSET and reSET-O (though Pear Therapeutics has since ceased operations) or Akili Interactive's EndeavorRx, which are specifically designed for certain conditions and require a prescription. The 'superiority' depends on the specific clinical need and the evidence base for each tool.
Wysa offers both free and premium versions. The free version provides access to basic conversational AI support and some tools, while the premium version (Wysa Premium) unlocks more advanced features, guided programs, and access to human coaches. Pricing for individual users typically involves a subscription model. For healthcare systems, Wysa offers enterprise solutions, and pricing would be negotiated based on the scale of deployment and specific features required, impacting patient access based on whether the healthcare provider covers the cost or if it's an out-of-pocket expense for the patient.
Wysa states that it is HIPAA compliant and adheres to GDPR regulations, ensuring patient data privacy and security. They employ encryption, secure servers, and anonymization techniques to protect sensitive mental health information. Wysa's privacy policy details their data handling practices, emphasizing that user data is not shared without consent and is used to improve the personalized experience while maintaining confidentiality.

Related Tools

Perimeter Medical Imaging AI
Perimeter Medical Imaging AI
Clinical Decision Support & Reference
The Claire OCT System by Perimeter Medical Imaging AI uses Optical Coherence Tomography and AI to provide real-time, high-resolution tissue imaging during surgery to help identify cancerous tissue.
Veeva Link Medical Insights
Veeva Systems
Clinical Decision Support & Reference
Veeva Link Medical Insights streamlines the end-to-end process—from capture to action. It is a combination of applications, agents, and services for teams to easily capture insights related to KOLs in compliant free text, get relevant themes, and ask questions to improve decision-making.
Semantic Clinical Artificial Intelligence (SCAI)
University at Buffalo (UB)
Clinical Decision Support & Reference
Semantic Clinical Artificial Intelligence (SCAI) is a clinical AI tool developed by University at Buffalo researchers that can respond to medical questions, demonstrating high accuracy on medical licensing exams and augmenting physician decision-making.
Prenaital
Prenaital
Clinical Decision Support & Reference
Prenaital uses AI to detect and manage high-risk pregnancies, enhancing the detection of conditions like abnormal fetal growth, preterm birth, and stillbirth.
PHQ Screeners (Pfizer)
Pfizer
Clinical Decision Support & Reference
PHQ Screeners is a free, open-access resource providing validated Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments for depression and anxiety, widely used for diagnosis and monitoring.
NeurixaHealthAI™
NeurixaHealthAI™
Clinical Decision Support & Reference
NeurixaHealthAI™ unifies fragmented patient data into a living population health engine to identify risk, close care gaps, and drive preventive interventions.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-06-19 | First Added: 2026-06-19

Investors who backed Wysa

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.